MSP-1014

N/A

Report date: 2024/01/24 16:55:33
NME

Base Information

Drug NameMSP-1014
Drug Alias NameMSP-1014MSP-1014.OX
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor agonists
TargetsSerotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsDepressive Disorder, Major
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMindset Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesClerkenwell Health
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, Major
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A